Table 2.
Follow-up time | 0–6 months | 6–12 months | 12–24 months |
---|---|---|---|
Number of patients | 266 | 247 | 193 |
MACE—n. (%) | 31 (11.7) | 16 (6.5) | 26 (13.5) |
SAQ < 70—n. (%) | 50 (18.8) | 51 (20.6) | 42 (21.8) |
MACE, major adverse cardiovascular events; SAQ, Seattle Angina Questionnaire.